Comparing ALGN and PAYC: A Deep Dive into Volatility, Price Growth, and Earnings Reports
Compare: Swing Trader for Beginners: Exits from Low Volatility to Explosive Movements (TA&FA) 6.32% for ALGN vs Swing Trader for Beginners: Trading in Markets Trending Up (TA&FA) 6.58% for PAYC
A Brief Overview of Swing Trading Strategies
To start, let's briefly touch on the Swing Trading strategies referenced for ALGN and PAYC. The Swing Trader for Beginners: Exits from Low Volatility to Explosive Movements (TA&FA) strategy delivered a strong performance for ALGN, while the Swing Trader for Beginners: Trading in Markets Trending Up (TA&FA) approach gave a strong performance for PAYC. Though these strategies have unique characteristics, both apply technical and fundamental analysis (TA&FA) to navigate market volatility and trends.
The Exits from Low Volatility to Explosive Movements strategy typically involves trading stocks that exhibit periods of low volatility followed by large price movements, whereas Trading in Markets Trending Up strategy generally capitalizes on securities in an upward market trend.
Weekly Price Growth: ALGN vs. PAYC
For the week, ALGN, which operates in the Medical Specialties industry, enjoyed a price increase of 2.56%. In contrast, PAYC, part of the Packaged Software industry, experienced a price drop of 2.34%.
When comparing these numbers to their respective industries, ALGN performed much stronger than its peers with an average weekly price drop of 0.89% in the Medical Specialties sector. PAYC, on the other hand, outperformed its industry, where the average weekly price drop was 1.07%.
Monthly and Quarterly Price Growth: An Industry Perspective
Taking a wider lens, the average monthly and quarterly price growth in the Medical Specialties industry (home to ALGN) was -0.37% and +7.41%, respectively. For the Packaged Software sector (home to PAYC), these figures were +3.70% and a robust +23.99%. The Packaged Software industry, hence, appears to have experienced higher growth over the more extended periods, underlining the importance of considering industry performance when comparing individual stocks.
Upcoming Earnings Reports
As for future expectations, both companies are due to report earnings soon. ALGN is set to announce its earnings on July 26, 2023, while PAYC is expected to report on August 1, 2023. These reports could potentially influence stock prices and should be closely monitored by investors.
In conclusion, while both ALGN and PAYC offer attractive opportunities for swing trading, they do so in distinct market contexts. Traders and investors should bear in mind these differences when devising their strategies and keep a keen eye on the upcoming earnings reports. The ongoing performance of these two companies reaffirms the importance of not only examining individual stocks but also the industries within which they operate.
Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.
ALGN moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend. In 34 of 41 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 83%.
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on ALGN as a result. In 58 of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.
The Moving Average Convergence Divergence (MACD) for ALGN just turned positive on October 08, 2026. Looking at past instances where ALGN's MACD turned positive, the stock continued to rise in 31 of 42 cases over the following month. The odds of a continued upward trend are 74%.
The 10-day moving average for ALGN crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 73%.
Following a +1.16% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALGN advanced for three days, in 190 of 272 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 43 of 63 cases where ALGN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 68%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
ALGN broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ALGN entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Seasonality Score of 6 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 47 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating fairly steady price growth. ALGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.587) is normal, around the industry mean (4.877). P/E Ratio (26.712) is within average values for comparable stocks, (37.682). Projected Growth (PEG Ratio) (0.611) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (2.612) is also within normal values, averaging (56.876).
The Tickeron SMR rating for this company is 69 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of the invisalign system for treating malocclusion
Industry PharmaceuticalsOther